Kurtoglu Metin — SEC Form 4 filings
SEC reporting owner CIK 2000284. 6 Form 4 filings on record with FilingPulse; latest filed 2025-01-07.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-04-10 to 2025-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 4 filings — 139,596 shares, $2,513,991 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 32,789 shares @ $16.67 ($546,560) in Cartesian Therapeutics, Inc., filed 2024-11-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Chief Technology Officer | 6 | — | 14 legs · 139,596 sh · $2,513,991 | 24 |
Form 4 filings — Kurtoglu Metin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-07 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Sale (S): 2,417 @ $16.72 · Sale (S): 2,458 @ $16.83 | EDGAR |
| 2025-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 16,100 @ $0 · Grant/award (A): 47,400 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 10,763 @ $1.41 · Sale (S): 6,224 @ $25.26 · Sale (S): 4,539 @ $25.83 · Option exercise (M): 2,901 @ $1.41 · Sale (S): 2,901 @ $24.35 · Option exercise (M): 10,763 (derivative) · +1 more | EDGAR |
| 2024-11-21 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 200 @ $1.41 · Sale (S): 200 @ $19.50 · Option exercise (M): 5,700 @ $1.41 · Sale (S): 5,600 @ $17.28 · Sale (S): 100 @ $18.09 · Option exercise (M): 32,789 @ $1.41 · +4 more | EDGAR |
| 2024-11-18 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 25,900 @ $1.41 · Sale (S): 21,900 @ $16.33 · Sale (S): 4,000 @ $17.06 · Option exercise (M): 22,068 @ $1.41 · Sale (S): 22,068 @ $17.20 · Option exercise (M): 34,400 @ $1.41 · +5 more | EDGAR |
| 2024-04-10 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 6,414.68 (derivative) · Option exercise (M): 213,820 (derivative) · Option exercise (M): 427.64 (derivative) · Option exercise (M): 14,254 (derivative) · Option exercise (M): 427.65 (derivative) · Option exercise (M): 14,254 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2000284 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →